Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor
CA 2097309 A1 · Owner: Distefano, Peter S. · Inventors: Distefano, Peter S.; Clagett-Dame, Margaret
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Monoclonal antibodies which specifically bind to human nerve growth factor receptor, human truncated nerve growth factor receptor monkey truncated nerve growth factor receptor and which do not , significantly bind to rat or chick nerve growth factor receptor and hybridomas which produce these monoclonal antibodies. Also provided are assays which utilize these monoclonal antibodies to determine the presence of human nerve growth factor receptor or human truncated nerve growth factor receptor in a test sample and, asssay kits containing these monoclonal antibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 2, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 2, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 2, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.